⌘K

Login Start Free

Home/Filings/4/0001415889-25-009201

4//SEC Filing

Higgins Jack 4

Accession 0001415889-25-009201

CIK 0001472012other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 5:54 PM ET

Size

6.9 KB

Accession

0001415889-25-009201

Insider Transaction Report

Form 4

Period: 2025-03-27

Immunome Inc.IMNM

Chief Scientific Officer

Transactions

Exercise/Conversion
Employee Stock option (right to buy)
2025-03-27−5,200→ 173,840 total
Exercise: $1.35Exp: 2032-06-23→ Common Stock (5,200 underlying)
Exercise/Conversion
Common Stock
2025-03-27$1.35/sh+5,200$7,020→ 18,729 total

Footnotes (1)

[F1]25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Documents

1 file

4
form4-03282025_090359.xmlPrimary

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1

filerCIK 0001993684

Filing Metadata

Form type: 4
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 5:54 PM ET
Size: 6.9 KB

View on SEC.gov